AI assistant
Sending…
Cardlytics, Inc. — Director's Dealing 2018
Feb 9, 2018
33956_dirs_2018-02-08_33e2fa3d-2da0-4b4a-a9fe-0af9518f6711.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2018-02-08
Reporting Person: Weisman Tony (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $9.08 | 2024-04-30 | Common Stock (25000) | Direct |
Footnotes
F1: Fully vested.
More from Cardlytics, Inc.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 19
Regulatory Filings
2026
Jan 26